The journal Genomics Proteomics ＆ Bioinformatics （GPB） is now inviting submissions for a special issue on the topic of ＂Big data for biomedicine＂ to be published in the spring of 2016.
The journal Genomics Proteomics ＆ Bioinformatics （GPB） is now inviting submissions for a special issue on the topic of ＂Big Data and Precision Medicine＂ to be published in the fall of 2016. For many complex disea...The journal Genomics Proteomics ＆ Bioinformatics （GPB） is now inviting submissions for a special issue on the topic of ＂Big Data and Precision Medicine＂ to be published in the fall of 2016. For many complex diseases, the traditional ＂one drug for one disease＂ scenario may soon become history. The new concept of ＂precision medicine＂ will heavily rely on the collection of large amount of data from the population as well as patients of specific diseases.展开更多
The journal Genomics Proteomics ＆ Bioinformatics （GPB）is now inviting submissions for a special issue on the topic of ＂Big Data and Precision Medicine＂ to be published in the fall of 2016. For many complex diseas...The journal Genomics Proteomics ＆ Bioinformatics （GPB）is now inviting submissions for a special issue on the topic of ＂Big Data and Precision Medicine＂ to be published in the fall of 2016. For many complex diseases, the traditional ＂one drug for one disease＂ scenario may soon become history. The new concept of ＂precision medicine＂ will heavily rely on the collection of large amount of data from the population as well as patients of specific diseases.展开更多
The journal Genomics Proteomics ＆ submissions for a special issue on the topic published in the fall of 2016. Bioinformatics （GPB） is now inviting of ＂Big Data and Precision Medicine＂ to be For many complex dise...The journal Genomics Proteomics ＆ submissions for a special issue on the topic published in the fall of 2016. Bioinformatics （GPB） is now inviting of ＂Big Data and Precision Medicine＂ to be For many complex diseases, the traditional ＂one drug for one disease＂ scenario may soon become history. The new concept of ＂precision medicine＂ will heavily rely on the collection of large amount of data from the population as well as patients of specific diseases. Thanks to the fast development of various omics technologies, including genomics, proteomics, and metabolomics, it has become increasingly feasible to gather high-dimensional omics data from the same subjects.展开更多
文摘The journal Genomics Proteomics ＆ Bioinformatics （GPB） is now inviting submissions for a special issue on the topic of ＂Big data for biomedicine＂ to be published in the spring of 2016.
文摘The journal Genomics Proteomics ＆ Bioinformatics （GPB） is now inviting submissions for a special issue on the topic of ＂Big Data and Precision Medicine＂ to be published in the fall of 2016. For many complex diseases, the traditional ＂one drug for one disease＂ scenario may soon become history. The new concept of ＂precision medicine＂ will heavily rely on the collection of large amount of data from the population as well as patients of specific diseases.
文摘The journal Genomics Proteomics ＆ Bioinformatics （GPB）is now inviting submissions for a special issue on the topic of ＂Big Data and Precision Medicine＂ to be published in the fall of 2016. For many complex diseases, the traditional ＂one drug for one disease＂ scenario may soon become history. The new concept of ＂precision medicine＂ will heavily rely on the collection of large amount of data from the population as well as patients of specific diseases.
文摘The journal Genomics Proteomics ＆ submissions for a special issue on the topic published in the fall of 2016. Bioinformatics （GPB） is now inviting of ＂Big Data and Precision Medicine＂ to be For many complex diseases, the traditional ＂one drug for one disease＂ scenario may soon become history. The new concept of ＂precision medicine＂ will heavily rely on the collection of large amount of data from the population as well as patients of specific diseases. Thanks to the fast development of various omics technologies, including genomics, proteomics, and metabolomics, it has become increasingly feasible to gather high-dimensional omics data from the same subjects.
